Rhumbline Advisers Acquires 41,780 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Rhumbline Advisers lifted its position in Stereotaxis, Inc. (NYSEAMERICAN:STXS – Free Report) by 645.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48,251 shares of the company’s stock after acquiring an additional 41,780 shares during the quarter. Rhumbline [...]

featured-image

Rhumbline Advisers lifted its position in Stereotaxis, Inc. ( NYSEAMERICAN:STXS – Free Report ) by 645.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC).

The institutional investor owned 48,251 shares of the company’s stock after acquiring an additional 41,780 shares during the quarter. Rhumbline Advisers owned approximately 0.06% of Stereotaxis worth $88,000 at the end of the most recent reporting period.



Several other institutional investors also recently modified their holdings of the business. Forum Financial Management LP bought a new stake in Stereotaxis during the 2nd quarter valued at $48,000. Bank of New York Mellon Corp grew its stake in Stereotaxis by 247.

5% during the second quarter. Bank of New York Mellon Corp now owns 189,592 shares of the company’s stock valued at $345,000 after acquiring an additional 135,041 shares in the last quarter. Virtu Financial LLC boosted its stake in Stereotaxis by 56.

0% during the first quarter. Virtu Financial LLC now owns 32,690 shares of the company’s stock valued at $85,000 after buying an additional 11,739 shares during the period. Vanguard Group Inc.

lifted its position in Stereotaxis by 7.7% during the first quarter. Vanguard Group Inc.

now owns 2,613,966 shares of the company’s stock valued at $6,822,000 after purchasing an additional 187,437 shares during the last quarter. Finally, SG Americas Securities LLC purchased a new stake in Stereotaxis during the first quarter valued at about $58,000. 45.

35% of the stock is owned by institutional investors. Stereotaxis Trading Down 0.7 % STXS stock opened at $2.

04 on Tuesday. The company has a market cap of $172.28 million, a price-to-earnings ratio of -7.

54 and a beta of 1.57. Stereotaxis, Inc.

has a one year low of $1.40 and a one year high of $3.29.

About Stereotaxis ( Free Report ) Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. Further Reading Five stocks we like better than Stereotaxis Unveiling The Power Of VWAP: A Key Indicator For Traders TJX Stock: A Buying Opportunity Before the Holiday Rush Uptrend Stocks Explained: Learn How to Trade Using Uptrends Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge What is Short Interest? How to Use It Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth Want to see what other hedge funds are holding STXS? Visit HoldingsChannel.

com to get the latest 13F filings and insider trades for Stereotaxis, Inc. ( NYSEAMERICAN:STXS – Free Report ). Receive News & Ratings for Stereotaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stereotaxis and related companies with MarketBeat.

com's FREE daily email newsletter ..